Improvement of adjuvant systems to obtain a cost-effective production of high levels of specific IgY

Poultry Science

Volumn 86, Issue 4, 2007, Pages 630-635

  Levesque S ^a   Martinez, G ^b   Fairbrother, J M ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

1 ,25 dihydroxyvitamin D3; Cytosine phosphate guanosine oligodeoxynucleotide; F4 (K88); Freund's adjuvant; Immunoglobulin yolk

Indexed keywords

ESCHERICHIA COLI; SUS;

FREUND ADJUVANT; IMMUNOGLOBULIN; IMMUNOGLOBULIN Y;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANADA; CHICKEN; COST BENEFIT ANALYSIS; ECONOMICS; EGG; EGG LAYING; FEMALE; IMMUNOLOGY;

ANIMALS; CHICKENS; COST-BENEFIT ANALYSIS; EGGS; FEMALE; FREUND'S ADJUVANT; IMMUNOGLOBULINS; OVIPOSITION; QUEBEC;

EID: 34548548460     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.1093/ps/86.4.630     Document Type: Article

References (32)

1. CCAC. 2002. Guidelines on Antibody Production. CCAC, Ottawa, Canada
2. Chang, H. M., R. F. Ou-Yang, Y. T. Chen, and C. C. Chen. 1999. Productivity and some properties of immunoglobulin specific against Streptococcus mutans serotype c in chicken egg yolk (IgY). J. Agric. Food Chem. 47:61-66.
3. Cho, S. H., P. C. Loewen, and R. R. Marquardt. 2004. A plasmid DNA encoding chicken interleukin-6 and Escherichia coli K88 fimbrial protein FaeG stimulates the production of anti-K88 fimbrial antibodies in chickens. Poult. Sci. 83:1973-1978.
4. Cook, S. R., S. J. Bach, S. M. Stevenson, R. DeVinney, A. A. Frohlich, L. Fang, and T. A. McAllister. 2005. Orally administered anti-Escherichia coli O157:H7 chicken egg yolk antibodies reduce fecal shedding of the pathogen by ruminants. Can. J. Anim. Sci. 85:291-299.
5. Erhard, M. H., K. Mahn, P. Schmidt, S. Oltmar, R. Preisinger, P. Zinsmeister, and M. Stangassinger. 2000. Evaluation of various immunisation procedures in laying hens to induce high amount of specific egg yolk antibodies. ATLA. 28:63-80.
6. Girard, F., I. Batisson, G. Martinez, C. Breton, J. Harel, and J. M. Fairbrother. 2006. Use of virulence factor-specific egg yolk-derived immunoglobulins as a promising alternative to antibiotics for prevention of attaching and effacing Escherichia coli infections. FEMS Immunol. Med. Microbiol. 46:340-350.
7. Gomis, S., L. Babiuk, B. Allan, P. Willson, E. Waters, N. Ambrose, R. Hecker, and A. Potter. 2004. Protection of neonatal chicks against a lethal challenge of Escherichia coli using DNA containing cytosine- phosphodiester-guanine motifs. Avian Dis. 48:813-822.
8. Hatta, H., M. Kim, and T. Yamamoto. 1990. A novel isolation method for hen egg yolk antibody, "IgY". Agric. Biol. Chem. 54:2531-2535.
9. He, H., T. L. Crippen, M. B. Farnell, and M. H. Kogut. 2003. Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells. Dev. Comp. Immunol. 27:621-627.
10. He, H., V. K. Lowry, P. J. Ferro, and M. H. Kogut. 2005. CpG-oligodeoxynucleotide-stimulated chicken heterophil degranulation is serum cofactor and cell surface receptor dependent. Dev. Comp. Immunol. 29:255-264.
11. Hemmi, H., and S. Akira. 2005. TLR signalling and the function of dendritic cells. Chem. Immunol. Allergy 86:120-135.
12. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
13. Ioannou, X. P., S. M. Gomis, B. Karvonen, R. Hecker, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2002. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21:127-137.
14. 3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J. Infect. Dis. 193:598-600.
15. Jacobs, A. A., and F. K. de Graaf. 1985. Production of K88, K99 and F41 fibrillae in relation to growth phase, and a rapid procedure for adhesin purification. FEMS Microbiol. Lett. 26:15-19.
16. Kehoe, M., R. Sellwood, P. Shipley, and G. Dougan. 1981. Genetic analysis of K88-mediated adhesion of enterotoxigenic Escherichia coli. Nature 291:122-126.
17. Kim, H. O., T. D. Durance, and E. C. Li-Chan. 1999. Reusability of avidin-biotinylated immunoglobulin Y columns in immunoaffinity chromatography. Anal. Biochem. 268:383-397.
18. Klinman, D. M., K. M. Barnhart, and J. Conover. 1999. CpG motifs as immune adjuvants. Vaccine 17:19-25.
19. Krieg, A. M., A. K. Yi, and G. Hartmann. 1999. Mechanisms and therapeutic applications of immune stimulatory cpG DNA. Pharmacol. Ther. 84:113-120.
20. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
21. 3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 17:1883-1888.
22. 3. J. Cell. Biochem. 49:26-31.
23. Markwell, M. A., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
24. Neural Notes. 1996. IgY polyclonal antibodies. Neural Notes 1:14-15.
25. Rankin, R., R. Pontarollo, X. Ioannou, A. M. Krieg, R. Hecker, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2001. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11:333-340.
26. Sands, H., L. J. Gorey-Feret, A. J. Cocuzza, F. W. Hobbs, D. Chidester, and G. L. Trainor. 1994. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. Mol. Pharmacol. 45:932-943.
27. Schade, R., C. Staak, C. Hendriksen, M. Erhard, H. Hugl, G. Koch, A. Larsson, W. Pollmann, M. van Regenmortel, E. Rijke, H. Spielmann, H. Steinbusch, and D. Straughan. 1996. The production of avian (egg yolk) antibodies:IgY. The report and recommendations of ECVAM workshop 21. ATLA. 24:925-934.
28. Sester, D. P., S. Naik, S. J. Beasley, D. A. Hume, and K. J. Stacey. 2000. Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J. Immunol. 165:4165-4173.
29. 3 or CpG-oligodeoxynucleotides. Vaccine 21:1023-1032.
30. 3 increases IgA serum antibody responses and IgA antibody-secreting cell numbers in the Peyer's patches of pigs after intramuscular immunization. Clin. Exp. Immunol. 135:380-390.
31. Vleugels, B., C. Ververken, and B. M. Goddeeris. 2002. Stimulatory effect of CpG sequences on humoral response in chickens. Poult. Sci. 81:1317-1321.
32. Wanke, R., P. Schmidt, M. H. Erhard, A. Sprick-Sanjose Messing, M. Stangassinger, W. Schmahl, and W. Hermanns. 1996. Freund's complete adjuvant in the chicken: Efficient immunostimulation with severe local inflammatory reaction. Zentralbl. Veterinarmed. A 43:243-253.